metaraminol has been researched along with Brain Embolism and Thrombosis in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, LS | 1 |
| Kennedy, JH | 1 |
| van Dellen, JR | 1 |
| Buchanan, N | 1 |
2 other studies available for metaraminol and Brain Embolism and Thrombosis
| Article | Year |
|---|---|
Atheromatous cerebral embolism. A complication of surgery of the thoracic aorta.
Topics: Aged; Aorta, Thoracic; Aortic Aneurysm; Dexamethasone; Heart Massage; Humans; Intracranial Embolism | 1967 |
Prolonged induced hypertension in the management of incipient cerebral infarction.
Topics: Arteriovenous Fistula; Blood Pressure; Carotid Artery, Internal; Cavernous Sinus; Female; Humans; In | 1977 |